Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials

Shuai Zhao; Fei Tian; Lan Yu; Zhenhua Li; Jing Hou; Yaochen Wei; Haozhe Cui; Shuqing Cui; Xiangming Ma

doi:https://doi.org/10.1007/s11739-026-04326-w

Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials

Identifier:nobleid.org/w1/20260421/C67408E2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C67408E2.svg?ark=w1%2F20260421%2FC67408E2)](https://nobleid.org/work/w1/20260421/C67408E2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials

Identifier:nobleid.org/w1/20260421/C67408E2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C67408E2.svg?ark=w1%2F20260421%2FC67408E2)](https://nobleid.org/work/w1/20260421/C67408E2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work